Steve is Head of Enterprise and Innovation leading innovation activities in the Medical School, and with external organisations including businesses and Wales NHS.
He is programme board member on two national precision medicine initiatives: Advanced Therapies Wales and Genome Partnerships Wales, where he chairs the Research and Innovation workstream. He sits on the Wales Cancer Research Centre executive, leading the Industry and Innovation theme.
Steve was a founding Director of the Centre for Nanohealth at Swansea University, an interdisciplinary R&D facility delivering advances in nanomedicine. He is now Strategic Director of the Celtic Advanced Life science Innovation Network (CALIN, www.calin.wales), an Ireland-Wales INTERREG operation building a life sciences innovation bridge between Wales (Bangor, Cardiff, Swansea) and Ireland (Cork, Dublin, Galway)
Steve is Professor of Molecular and Cell Biology, heading up the vibrant Reproductive Biology and Gynaecological Oncology research group.
His research focuses on the application of molecular, cellular and nano biology to understand gynaecological pathologies including cancer and infertility. He is currently working on disease related transcription and epigenetic processes, and the development of advanced therapeutics: Antibody Drug Conjugates (pre-clinical development), exosomes, and nanoparticle deliver systems
Steve is a Fellow of the Royal Society of Biology (FRSB), and a Trustee of the British Society of Nanomedicine. He is a Senior Affiliate Member of The Methodist Hospital Research Institute, Houston, Texas, Distinguished Professor at Xi'an Jiaotong University, Suzhou Academy, China, and honorary consultant in the Swansea Bay University health Board.